Device Trial Radar · NCT06881667
US Development and Evaluation Study of a Patch-Based PSG System
Last checked: Nov 20, 2026Latest source record: Mar 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
70
Actual
Start
Aug 4, 2023
Primary completion
Sep 2, 2024
Study completion Sep 2, 2024
Sponsor
- Lead sponsor
- Onera BVNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 18, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is continue the development and evaluation of the Onera system as well as the procedures and best practices for dispensing, instruction, use and reportability of results.
Conditions
- Sleep Disorder (Disorder)
Interventions
Home PSG AssessmentDevice
Testing of the Onera STS in the home environment with the current device shipment method and instructions.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Study Success RateTime frame: Assessment will be completed within one month after completion of the sleep study.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
The Sleep Disorders Center of Alabama
Birmingham, Alabama
Clayton Sleep Institute
St Louis, Missouri
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.